GY037 A Phase III study of induction pembrolizumab and chemotherapy followed by chemoradiation and pembrolizumab versus chemoradiation and pembrolizumab both followed by pembrolizumab for high risk locally advanced cervical cancer

  • Phase III
  • Trial Category: Gynecologic

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Methodist Estabrook Cancer Center

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*